AXICABTAGENE CILOLEUCEL

AXICABTAGENE CILOLEUCEL was reported 10160 times

AXICABTAGENE CILOLEUCEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 115 0.9274
1 CYTOKINE INCREASED 76 0.5630
2 BCG RELATED CYSTITIS 9 0.4500
3 LYMPHOCYTE ADOPTIVE THERAPY 107 0.3835
4 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2149 0.3625
5 MALIGNANT GENITOURINARY TRACT NEOPLASM 24 0.3582
6 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 58 0.3333
7 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 14 0.2745
8 HIGH GRADE B-CELL LYMPHOMA RECURRENT 3 0.2727
9 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 28 0.2393
10 CYTOKINE RELEASE SYNDROME 4622 0.2302
11 CHEMOTHERAPY NEUROTOXICITY ATTENUATION 2 0.2222
12 APHERESIS RELATED COMPLICATION 3 0.2000
13 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT 9 0.1957
14 B-CELL APLASIA 46 0.1783
15 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 19 0.1258
16 HUMAN HERPESVIRUS 6 ENCEPHALITIS 33 0.1162
17 B-CELL UNCLASSIFIABLE LYMPHOMA HIGH GRADE 2 0.1000
18 GENITOURINARY TRACT NEOPLASM 8 0.0964
19 MENINGOMYELITIS HERPES 3 0.0938
20 HIGH-GRADE B-CELL LYMPHOMA 15 0.0802
21 REFRACTORY CANCER 17 0.0794
22 NEUROTOXICITY 1381 0.0787
23 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 5 0.0769
24 CYTOKINE STORM 46 0.0672
25 CARDIORENAL SYNDROME 37 0.0646
26 HIPPOCAMPAL ATROPHY 2 0.0606
27 B-CELL LYMPHOMA RECURRENT 29 0.0534
28 SARCOMATOID MESOTHELIOMA 4 0.0533
29 DIFFUSE LARGE B-CELL LYMPHOMA 403 0.0522
30 HISTIOCYTIC SARCOMA 4 0.0513
31 CELL-MEDIATED IMMUNE DEFICIENCY 7 0.0500
32 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 106 0.0480
33 ACALCULIA 3 0.0462
34 ADENOVIRAL HAEMORRHAGIC CYSTITIS 9 0.0433
35 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 5 0.0410
36 ROSEOLOVIRUS TEST POSITIVE 5 0.0410
37 CYTOKINE ABNORMAL 2 0.0385
38 AMERICAN TRYPANOSOMIASIS 10 0.0370
39 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 12 0.0366
40 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 34 0.0359
41 METASTATIC LYMPHOMA 14 0.0358
42 PSEUDOMONAL BACTERAEMIA 30 0.0351
43 HERPES ZOSTER REACTIVATION 9 0.0344
44 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 47 0.0335
45 BORDETELLA INFECTION 3 0.0333
46 NATURAL KILLER CELL COUNT DECREASED 3 0.0326
47 LARGE GRANULAR LYMPHOCYTOSIS 10 0.0298
48 CONGENITAL APLASIA 9 0.0289
49 DYSCALCULIA 7 0.0283
50 ENCEPHALITIS CYTOMEGALOVIRUS 12 0.0274
51 HYPOGLOBULINAEMIA 3 0.0265
52 HYPOFIBRINOGENAEMIA 26 0.0262
53 FOLLICULAR LYMPHOMA RECURRENT 2 0.0250
54 HYPOGAMMAGLOBULINAEMIA 164 0.0249
55 BLOOD IMMUNOGLOBULIN G DECREASED 60 0.0242
56 RHODOCOCCUS INFECTION 4 0.0241
57 T-CELL LYMPHOMA 26 0.0227
58 B-CELL LYMPHOMA REFRACTORY 2 0.0225
59 BLOOD FIBRINOGEN DECREASED 24 0.0210
60 ADENOVIRUS REACTIVATION 3 0.0208
61 FOLLICULAR LYMPHOMA 18 0.0205
62 MYELODYSPLASTIC SYNDROME 295 0.0204
63 AUTOIMMUNE ENCEPHALOPATHY 2 0.0198
64 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 8 0.0197
65 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 143 0.0190
66 SERUM FERRITIN INCREASED 100 0.0189
67 SPLENIC LESION 7 0.0189
68 UROGENITAL HAEMORRHAGE 7 0.0188
69 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 11 0.0185
70 ALANINE AMINOTRANSFERASE 4 0.0181
71 MYELOPROLIFERATIVE NEOPLASM 11 0.0166
72 ACUTE MONOCYTIC LEUKAEMIA 3 0.0165
73 AMNESTIC DISORDER 8 0.0164
74 SQUAMOUS CELL CARCINOMA OF SKIN 99 0.0164
75 CYTOPENIA 199 0.0162
76 MIXED ANXIETY AND DEPRESSIVE DISORDER 6 0.0162
77 CYTOMEGALOVIRUS INFECTION REACTIVATION 71 0.0161
78 TUMOUR PSEUDOPROGRESSION 17 0.0155
79 AUTOIMMUNE NEUROPATHY 2 0.0155
80 HYPOALBUMINAEMIA 114 0.0146
81 PULSE PRESSURE INCREASED 3 0.0145
82 INTERLEUKIN LEVEL INCREASED 8 0.0145
83 SOFT TISSUE SARCOMA 5 0.0143
84 DIVERTICULITIS INTESTINAL PERFORATED 5 0.0140
85 B-CELL LYMPHOMA 46 0.0135
86 DYSGRAPHIA 87 0.0132
87 MANUFACTURING ISSUE 6 0.0129
88 ACTION TREMOR 2 0.0123
89 INFECTION REACTIVATION 14 0.0122
90 NEPHROSTOMY 4 0.0121
91 ENCEPHALOPATHY 292 0.0119
92 T-LYMPHOCYTE COUNT DECREASED 8 0.0117
93 IMMUNOGLOBULINS ABNORMAL 3 0.0115
94 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 4 0.0114
95 NONINFECTIVE ENCEPHALITIS 8 0.0111
96 LIMBIC ENCEPHALITIS 3 0.0109
97 SPINAL CORD OEDEMA 4 0.0108
98 CYTOMEGALOVIRUS VIRAEMIA 48 0.0108
99 ANISOCORIA 4 0.0106
100 HAEMOFILTRATION 2 0.0105
101 PNEUMONIA PSEUDOMONAL 16 0.0104
102 ENTEROCOCCAL BACTERAEMIA 11 0.0104
103 COLON NEOPLASM 10 0.0104
104 MYELITIS 16 0.0103
105 ACINETOBACTER TEST POSITIVE 2 0.0103
106 SYSTEMIC MYCOSIS 12 0.0103
107 TUMOUR INVASION 5 0.0103
108 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 2 0.0103
109 ALANINE AMINOTRANSFERASE ABNORMAL 21 0.0099
110 ADENOCARCINOMA METASTATIC 2 0.0097
111 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 3 0.0096
112 BLOOD PRODUCT TRANSFUSION DEPENDENT 4 0.0095
113 EOSINOPHILIC CELLULITIS 2 0.0094
114 CLOSTRIDIUM BACTERAEMIA 2 0.0093
115 MYELITIS TRANSVERSE 13 0.0092
116 PARAINFLUENZAE VIRUS INFECTION 14 0.0092
117 PHYSICAL DECONDITIONING 23 0.0089
118 ESCHERICHIA BACTERAEMIA 21 0.0089
119 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34 0.0089
120 FUNGAEMIA 14 0.0089
121 HYPOPHOSPHATAEMIA 65 0.0088
122 SYSTEMIC CANDIDA 22 0.0088
123 URINARY TRACT INFECTION ENTEROCOCCAL 8 0.0086
124 CRANIAL NERVE PARALYSIS 4 0.0084
125 CREST SYNDROME 2 0.0084
126 VOCAL CORD PARALYSIS 15 0.0084
127 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 7 0.0083
128 CLOSTRIDIAL SEPSIS 2 0.0083
129 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
130 IMMUNOGLOBULINS DECREASED 11 0.0080
131 APHASIA 242 0.0080
132 CYSTITIS VIRAL 3 0.0078
133 ENTEROCOCCUS TEST POSITIVE 5 0.0077
134 LOWER RESPIRATORY TRACT INFECTION FUNGAL 3 0.0077
135 PNEUMOCOCCAL SEPSIS 5 0.0076
136 SMALL INTESTINAL PERFORATION 14 0.0075
137 ACUTE MYELOID LEUKAEMIA 116 0.0074
138 SCROTAL PAIN 4 0.0074
139 MYELOPATHY 14 0.0074
140 TUMOUR ASSOCIATED FEVER 3 0.0073
141 CENTRAL NERVOUS SYSTEM LYMPHOMA 10 0.0073
142 CAMPYLOBACTER INFECTION 6 0.0072
143 CANDIDA TEST POSITIVE 3 0.0072
144 APLASIA 14 0.0071
145 DISEASE PROGRESSION 842 0.0071
146 BRAIN OEDEMA 89 0.0070
147 PLATELET TRANSFUSION 9 0.0070
148 HYPERFERRITINAEMIA 3 0.0070
149 HUMAN HERPESVIRUS 6 INFECTION 13 0.0069
150 HYPOPROTEINAEMIA 13 0.0068
151 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 2 0.0068
152 POSTRENAL FAILURE 3 0.0068
153 CAMPYLOBACTER GASTROENTERITIS 4 0.0067
154 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 2 0.0067
155 URINARY TRACT INFECTION PSEUDOMONAL 4 0.0067
156 B-LYMPHOCYTE COUNT DECREASED 9 0.0066
157 ENTEROBACTER BACTERAEMIA 2 0.0066
158 PNEUMONIA FUNGAL 26 0.0066
159 FEBRILE BONE MARROW APLASIA 28 0.0066
160 LYMPHOCYTE COUNT DECREASED 116 0.0066
161 ASPERGILLUS INFECTION 43 0.0065
162 ANAL SQUAMOUS CELL CARCINOMA 2 0.0065
163 MENINGISM 3 0.0064
164 BRONCHOPULMONARY ASPERGILLOSIS 49 0.0063
165 KLEBSIELLA SEPSIS 7 0.0062
166 PNEUMONIA NECROTISING 4 0.0062
167 ENTEROCOCCAL SEPSIS 5 0.0062
168 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
169 KLEBSIELLA TEST POSITIVE 4 0.0061
170 HYPOXIA 213 0.0060
171 STARVATION 5 0.0060
172 STAPHYLOCOCCAL BACTERAEMIA 26 0.0060
173 PRODUCT BLISTER PACKAGING ISSUE 6 0.0058
174 SKIN CANDIDA 3 0.0057
175 PULMONARY MUCORMYCOSIS 3 0.0057
176 JC VIRUS INFECTION 9 0.0056
177 NEUROLOGICAL DECOMPENSATION 13 0.0056
178 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
179 PARAPLEGIA 16 0.0055
180 CEREBRAL MASS EFFECT 2 0.0055
181 NEUROLOGICAL SYMPTOM 31 0.0054
182 BRAIN HERNIATION 16 0.0054
183 INTENTION TREMOR 3 0.0053
184 KLEBSIELLA BACTERAEMIA 5 0.0053
185 ACUTE PHASE REACTION 2 0.0052
186 CENTRAL NERVOUS SYSTEM INFECTION 6 0.0052
187 TUMOUR LYSIS SYNDROME 46 0.0052
188 BACTERAEMIA 62 0.0052
189 CEREBELLAR STROKE 2 0.0051
190 AGRAPHIA 3 0.0050
191 MUCORMYCOSIS 13 0.0050
192 ECTHYMA 2 0.0050
193 DYSMETRIA 3 0.0050
194 SECOND PRIMARY MALIGNANCY 41 0.0049
195 POST-ACUTE COVID-19 SYNDROME 6 0.0048
196 ADENOVIRUS INFECTION 14 0.0048
197 PANCYTOPENIA 268 0.0048
198 CEREBRAL VENOUS SINUS THROMBOSIS 4 0.0047
199 APRAXIA 7 0.0047
200 AUTOIMMUNE COLITIS 3 0.0047
201 FEBRILE NEUTROPENIA 308 0.0046
202 NEUTROPHIL COUNT DECREASED 184 0.0045
203 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 37 0.0045
204 GASTRIC FISTULA 2 0.0045
205 BK VIRUS INFECTION 15 0.0044
206 RECURRENT CANCER 18 0.0044
207 TUMOUR FLARE 3 0.0044
208 RHINOVIRUS INFECTION 17 0.0044
209 ENTEROCOCCAL INFECTION 21 0.0043
210 LYMPHOMA 67 0.0043
211 LYMPHOPENIA 61 0.0043
212 ENDOTRACHEAL INTUBATION 12 0.0043
213 PROCALCITONIN INCREASED 5 0.0043
214 STATUS EPILEPTICUS 48 0.0042
215 INTENSIVE CARE 6 0.0042
216 DYSPLASIA 5 0.0042
217 CEREBELLAR INFARCTION 7 0.0041
218 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 21 0.0041
219 BONE MARROW FAILURE 83 0.0041
220 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
221 DEVICE RELATED THROMBOSIS 4 0.0041
222 BACTERIAL SEPSIS 13 0.0040
223 DEVICE RELATED SEPSIS 8 0.0040
224 HYPOMAGNESAEMIA 55 0.0039
225 C-REACTIVE PROTEIN INCREASED 143 0.0039
226 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
227 GASTROINTESTINAL FUNGAL INFECTION 2 0.0039
228 HYPERVOLAEMIA 19 0.0038
229 NEUTROPENIA 520 0.0038
230 ELECTROENCEPHALOGRAM ABNORMAL 12 0.0038
231 ESCHERICHIA SEPSIS 11 0.0038
232 BRAIN MIDLINE SHIFT 2 0.0038
233 CYSTITIS HAEMORRHAGIC 15 0.0037
234 STREPTOCOCCAL BACTERAEMIA 4 0.0037
235 GASTROINTESTINAL PERFORATION 15 0.0036
236 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
237 ESSENTIAL TREMOR 4 0.0036
238 ENTEROBACTER INFECTION 6 0.0036
239 DYSPRAXIA 2 0.0035
240 INCONTINENCE 37 0.0035
241 ENANTHEMA 2 0.0035
242 MUTISM 5 0.0034
243 HYPOTHALAMO-PITUITARY DISORDER 5 0.0034
244 SEPTIC SHOCK 148 0.0034
245 HYPERBILIRUBINAEMIA 35 0.0034
246 PNEUMONIA BACTERIAL 31 0.0034
247 HAEMATOTOXICITY 32 0.0034
248 ESCHERICHIA TEST POSITIVE 4 0.0033
249 LISTLESS 11 0.0033
250 MONOPARESIS 6 0.0033
251 CYTOMEGALOVIRUS INFECTION 55 0.0033
252 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
253 LANGUAGE DISORDER 7 0.0032
254 LEUKOENCEPHALOPATHY 12 0.0032
255 BASAL CELL CARCINOMA 50 0.0032
256 MENTAL STATUS CHANGES 89 0.0032
257 CLOSTRIDIUM TEST POSITIVE 7 0.0032
258 HYPOCALCAEMIA 60 0.0032
259 METASTASES TO PERITONEUM 8 0.0032
260 MULTIPLE ORGAN DYSFUNCTION SYNDROME 88 0.0031
261 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
262 CELLULITIS STAPHYLOCOCCAL 2 0.0031
263 LYMPHOPROLIFERATIVE DISORDER 9 0.0031
264 BRADYPHRENIA 20 0.0031
265 HAEMOPHILUS INFECTION 3 0.0031
266 FASCIITIS 2 0.0030
267 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
268 AGRANULOCYTOSIS 56 0.0030
269 BLOOD CULTURE POSITIVE 9 0.0030
270 METABOLIC ENCEPHALOPATHY 9 0.0030
271 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
272 BONE MARROW DISORDER 9 0.0030
273 AUTONOMIC NEUROPATHY 3 0.0030
274 STENOTROPHOMONAS INFECTION 4 0.0029
275 BRAIN STEM INFARCTION 3 0.0029
276 PUPIL FIXED 5 0.0029
277 SLOW SPEECH 7 0.0029
278 TACHYPNOEA 39 0.0029
279 TUMOUR NECROSIS 3 0.0028
280 HYPERPYREXIA 12 0.0028
281 POLYOMAVIRUS VIRAEMIA 3 0.0028
282 CD4 LYMPHOCYTES DECREASED 6 0.0028
283 TOXIC ENCEPHALOPATHY 14 0.0028
284 THROMBOCYTOPENIA 305 0.0027
285 RETROPERITONEAL HAEMATOMA 6 0.0027
286 EPSTEIN-BARR VIRAEMIA 3 0.0027
287 PNEUMOPERITONEUM 5 0.0027
288 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
289 PSEUDOMONAS INFECTION 23 0.0027
290 BRAIN STEM SYNDROME 2 0.0027
291 PYREXIA 906 0.0026
292 PAROTITIS 3 0.0026
293 JC POLYOMAVIRUS TEST POSITIVE 3 0.0026
294 HYPERTENSIVE EMERGENCY 3 0.0025
295 STREPTOCOCCAL SEPSIS 3 0.0025
296 PNEUMONIA INFLUENZAL 3 0.0025
297 NON-SMALL CELL LUNG CANCER 12 0.0025
298 HAEMOPERITONEUM 2 0.0025
299 HERPES ZOSTER DISSEMINATED 2 0.0025
300 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
301 HAPTOGLOBIN DECREASED 2 0.0025
302 HAEMATOLOGICAL INFECTION 6 0.0025
303 DISORIENTATION 97 0.0024
304 HYPERTRANSAMINASAEMIA 17 0.0024
305 OXYGEN THERAPY 4 0.0024
306 QUADRIPLEGIA 5 0.0024
307 VASCULAR DEVICE INFECTION 11 0.0024
308 CSF PROTEIN INCREASED 2 0.0024
309 ADRENAL MASS 2 0.0024
310 FUNGAL SEPSIS 2 0.0024
311 INTESTINAL PERFORATION 27 0.0024
312 STEM CELL TRANSPLANT 6 0.0024
313 SEIZURE LIKE PHENOMENA 4 0.0024
314 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
315 AXONAL NEUROPATHY 2 0.0023
316 PSEUDOMONAL SEPSIS 4 0.0023
317 GASTROENTERITIS NOROVIRUS 3 0.0023
318 ANOGENITAL WARTS 2 0.0022
319 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
320 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
321 MALNUTRITION 25 0.0022
322 MENINGITIS ASEPTIC 10 0.0022
323 MENINGITIS VIRAL 3 0.0022
324 HYPOKALAEMIA 101 0.0022
325 ASPARTATE AMINOTRANSFERASE INCREASED 116 0.0022
326 PNEUMONIA KLEBSIELLA 4 0.0022
327 PULMONARY HAEMORRHAGE 17 0.0022
328 ENCEPHALITIS 15 0.0022
329 VIRAEMIA 3 0.0022
330 LOCALISED OEDEMA 10 0.0022
331 CEREBRAL TOXOPLASMOSIS 2 0.0021
332 CULTURE URINE POSITIVE 3 0.0021
333 BRAIN STEM HAEMORRHAGE 2 0.0021
334 CARDIAC TAMPONADE 10 0.0021
335 LONG QT SYNDROME 5 0.0021
336 DIABETES INSIPIDUS 5 0.0021
337 ESCHERICHIA INFECTION 17 0.0021
338 PULMONARY SEPSIS 3 0.0021
339 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
340 TRANSPLANT FAILURE 5 0.0020
341 NERVOUS SYSTEM DISORDER 63 0.0020
342 TACHYCARDIA 179 0.0020
343 HYPOTENSION 400 0.0020
344 BACTERIAL INFECTION 37 0.0020
345 DIVERTICULAR PERFORATION 4 0.0019
346 CAPILLARY LEAK SYNDROME 4 0.0019
347 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
348 COGWHEEL RIGIDITY 2 0.0019
349 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
350 ECCHYMOSIS 13 0.0019
351 NEUROGENIC BLADDER 4 0.0019
352 CONFUSIONAL STATE 306 0.0019
353 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
354 ASTERIXIS 2 0.0019
355 ABDOMINAL MASS 5 0.0019
356 GUILLAIN-BARRE SYNDROME 9 0.0019
357 HEPATIC LESION 8 0.0018
358 COMMUNICATION DISORDER 7 0.0018
359 NEUTROPENIC SEPSIS 13 0.0018
360 INTESTINAL ISCHAEMIA 10 0.0018
361 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
362 SKIN INJURY 6 0.0018
363 HYPERNATRAEMIA 9 0.0018
364 CARDIOPULMONARY FAILURE 7 0.0018
365 THERAPY PARTIAL RESPONDER 28 0.0018
366 KLEBSIELLA INFECTION 9 0.0018
367 MALIGNANT PLEURAL EFFUSION 3 0.0018
368 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
369 CYTOGENETIC ABNORMALITY 2 0.0018
370 DISTRIBUTIVE SHOCK 4 0.0018
371 ENTERITIS INFECTIOUS 3 0.0018
372 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
373 ARTERIAL HAEMORRHAGE 2 0.0017
374 NEOPLASM 20 0.0017
375 CEREBRAL VENTRICLE DILATATION 2 0.0017
376 PLATELET COUNT DECREASED 185 0.0017
377 STRESS CARDIOMYOPATHY 10 0.0017
378 PARTIAL SEIZURES 9 0.0017
379 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
380 HAEMATOMA MUSCLE 2 0.0017
381 CLOSTRIDIUM COLITIS 2 0.0016
382 DELIRIUM 57 0.0016
383 FACIAL PARALYSIS 14 0.0016
384 BODY TEMPERATURE ABNORMAL 3 0.0016
385 DISORGANISED SPEECH 3 0.0016
386 RETROPERITONEAL HAEMORRHAGE 4 0.0016
387 BRAIN DEATH 5 0.0016
388 MULTIPLE-DRUG RESISTANCE 5 0.0016
389 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
390 COVID-19 PNEUMONIA 19 0.0016
391 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
392 NASAL OBSTRUCTION 3 0.0016
393 NON-CARDIAC CHEST PAIN 5 0.0016
394 DISEASE RECURRENCE 75 0.0016
395 HAEMODYNAMIC INSTABILITY 12 0.0016
396 PNEUMONIA VIRAL 5 0.0016
397 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
398 MYELOSUPPRESSION 56 0.0016
399 PYELONEPHRITIS ACUTE 3 0.0015
400 RENAL TUBULAR NECROSIS 15 0.0015
401 MULTI-ORGAN DISORDER 3 0.0015
402 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
403 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
404 EMPYEMA 3 0.0015
405 COAGULOPATHY 25 0.0015
406 PLEURAL EFFUSION 91 0.0015
407 CARDIOMYOPATHY 22 0.0015
408 SQUAMOUS CELL CARCINOMA 14 0.0015
409 PURPURA 13 0.0015
410 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
411 SUBDURAL HAEMORRHAGE 4 0.0015
412 VENTRICULAR TACHYCARDIA 24 0.0015
413 NEUTROPENIC COLITIS 3 0.0014
414 HYPERTHERMIA 11 0.0014
415 INTRACRANIAL PRESSURE INCREASED 8 0.0014
416 CANDIDA INFECTION 24 0.0014
417 EMBOLIC STROKE 5 0.0014
418 MALIGNANT MELANOMA 19 0.0014
419 EJECTION FRACTION DECREASED 22 0.0014
420 ACUTE RESPIRATORY FAILURE 27 0.0014
421 HYPOTONIA 14 0.0014
422 TREMOR 232 0.0014
423 GASTROINTESTINAL NECROSIS 4 0.0014
424 ASPIRATION 15 0.0014
425 CEREBELLAR SYNDROME 3 0.0014
426 EXCESSIVE EYE BLINKING 2 0.0014
427 CEREBRAL DISORDER 10 0.0014
428 TRANSAMINASES INCREASED 30 0.0013
429 FAILURE TO THRIVE 7 0.0013
430 WHITE BLOOD CELL COUNT DECREASED 146 0.0013
431 AXILLARY PAIN 2 0.0013
432 PETECHIAE 14 0.0013
433 MYOCLONUS 16 0.0013
434 GASTROINTESTINAL WALL THICKENING 2 0.0013
435 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
436 ORTHOSTATIC HYPOTENSION 23 0.0013
437 METASTASES TO MENINGES 3 0.0013
438 SEPSIS 147 0.0013
439 LICHENOID KERATOSIS 3 0.0013
440 CYTOMEGALOVIRUS COLITIS 3 0.0013
441 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
442 FLAT AFFECT 3 0.0013
443 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
444 ANAEMIA 245 0.0013
445 MOTOR DYSFUNCTION 13 0.0013
446 URINARY TRACT OBSTRUCTION 3 0.0013
447 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
448 HYPONATRAEMIA 71 0.0013
449 IMMUNOSUPPRESSION 11 0.0012
450 STARING 3 0.0012
451 UNRESPONSIVE TO STIMULI 32 0.0012
452 ACUTE LEUKAEMIA 2 0.0012
453 HERPES SIMPLEX 8 0.0012
454 DEATH 1056 0.0012
455 RESPIRATORY FAILURE 89 0.0012
456 STAPHYLOCOCCAL SEPSIS 6 0.0012
457 ACUTE PSYCHOSIS 3 0.0012
458 GASTROINTESTINAL TUBE INSERTION 3 0.0012
459 SINUS TACHYCARDIA 17 0.0012
460 TONGUE ULCERATION 4 0.0012
461 COGNITIVE DISORDER 55 0.0012
462 ACIDOSIS 9 0.0012
463 GAZE PALSY 2 0.0012
464 SHOCK 27 0.0012
465 CANCER PAIN 3 0.0012
466 ATRIAL FIBRILLATION 114 0.0012
467 ADRENAL INSUFFICIENCY 14 0.0012
468 GENERALISED OEDEMA 14 0.0011
469 FIBRIN D DIMER INCREASED 4 0.0011
470 AREFLEXIA 3 0.0011
471 CONJUNCTIVAL HYPERAEMIA 4 0.0011
472 INFECTION 162 0.0011
473 GRAFT VERSUS HOST DISEASE 8 0.0011
474 THERAPY NON-RESPONDER 50 0.0011
475 SHOCK HAEMORRHAGIC 9 0.0011
476 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
477 BRAIN INJURY 11 0.0011
478 ULCERATIVE KERATITIS 3 0.0011
479 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
480 AGITATION 79 0.0011
481 CARDIAC DYSFUNCTION 4 0.0011
482 BLOOD BILIRUBIN INCREASED 29 0.0011
483 LUNG CONSOLIDATION 3 0.0011
484 HEMIPARESIS 18 0.0011
485 ASCITES 31 0.0011
486 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
487 HEPATIC MASS 2 0.0010
488 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
489 SINUS BRADYCARDIA 10 0.0010
490 SPLENOMEGALY 12 0.0010
491 BICYTOPENIA 2 0.0010
492 STRIDOR 3 0.0010
493 RESPIRATORY ACIDOSIS 4 0.0010
494 DIPLEGIA 2 0.0010
495 INFLAMMATORY MARKER INCREASED 5 0.0010
496 CELL DEATH 2 0.0010
497 IMMUNODEFICIENCY 15 0.0010
498 CEREBRAL ATROPHY 4 0.0010
499 ATYPICAL PNEUMONIA 3 0.0010
500 LUNG ADENOCARCINOMA 3 0.0010
501 DERMATITIS BULLOUS 7 0.0010
502 SEIZURE 111 0.0010
503 APLASTIC ANAEMIA 5 0.0010
504 BLOOD LACTIC ACID INCREASED 5 0.0009
505 HEPATITIS B REACTIVATION 3 0.0009
506 NYSTAGMUS 5 0.0009
507 HEPATIC CYTOLYSIS 12 0.0009
508 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
509 LYMPHADENOPATHY 33 0.0009
510 EPILEPSY 28 0.0009
511 SARS-COV-2 TEST POSITIVE 12 0.0009
512 CORONAVIRUS INFECTION 6 0.0009
513 FUNGAL INFECTION 30 0.0009
514 STREPTOCOCCAL INFECTION 5 0.0009
515 BACTERIAL TEST POSITIVE 2 0.0009
516 HAEMOLYTIC ANAEMIA 8 0.0009
517 ADENOCARCINOMA 2 0.0009
518 INFUSION RELATED REACTION 59 0.0009
519 PAPILLOEDEMA 4 0.0009
520 CARDIO-RESPIRATORY ARREST 37 0.0009
521 COVID-19 154 0.0009
522 ATRIAL FLUTTER 7 0.0009
523 SKIN LESION 24 0.0009
524 ISCHAEMIA 4 0.0009
525 SENSORY LOSS 7 0.0009
526 BLOOD CREATININE ABNORMAL 3 0.0009
527 PERICARDIAL EFFUSION 20 0.0009
528 TRANSFUSION 9 0.0009
529 RASH MACULO-PAPULAR 19 0.0009
530 NECROTISING FASCIITIS 3 0.0009
531 DIALYSIS 12 0.0008
532 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
533 ATELECTASIS 8 0.0008
534 FLUID OVERLOAD 12 0.0008
535 THROMBOTIC MICROANGIOPATHY 8 0.0008
536 PARKINSONISM 8 0.0008
537 LEUKOPENIA 41 0.0008
538 COMA 39 0.0008
539 ORGANISING PNEUMONIA 4 0.0008
540 OLIGURIA 5 0.0008
541 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
542 MEMORY IMPAIRMENT 110 0.0008
543 IMPULSIVE BEHAVIOUR 3 0.0008
544 HEPATIC FAILURE 24 0.0008
545 LUNG INFILTRATION 7 0.0008
546 STAPHYLOCOCCAL INFECTION 26 0.0008
547 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
548 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
549 SOMNOLENCE 158 0.0008
550 ABDOMINAL INFECTION 2 0.0008
551 ENDOCARDITIS 4 0.0008
552 GASTROINTESTINAL CARCINOMA 7 0.0008
553 SPINAL CORD COMPRESSION 3 0.0008
554 ORAL INFECTION 3 0.0008
555 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
556 PNEUMONIA ASPIRATION 19 0.0008
557 EXFOLIATIVE RASH 2 0.0008
558 ATAXIA 9 0.0008
559 HALLUCINATION, VISUAL 16 0.0008
560 CHOLECYSTITIS 9 0.0008
561 AZOTAEMIA 3 0.0008
562 NEOPLASM PROGRESSION 26 0.0007
563 ORGAN FAILURE 3 0.0007
564 DYSARTHRIA 28 0.0007
565 GASTROINTESTINAL INJURY 2 0.0007
566 BRADYPNOEA 2 0.0007
567 HYDROCEPHALUS 4 0.0007
568 SMALL INTESTINAL OBSTRUCTION 9 0.0007
569 HYPERCALCAEMIA 9 0.0007
570 ILL-DEFINED DISORDER 44 0.0007
571 EMBOLISM 6 0.0007
572 CHOLECYSTITIS INFECTIVE 2 0.0007
573 VENTRICULAR FIBRILLATION 8 0.0007
574 ACUTE PULMONARY OEDEMA 4 0.0007
575 ACUTE KIDNEY INJURY 109 0.0007
576 VITREOUS FLOATERS 7 0.0007
577 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
578 CHOLECYSTITIS ACUTE 4 0.0007
579 GRANULOCYTOPENIA 4 0.0007
580 RETINAL HAEMORRHAGE 5 0.0007
581 PARALYSIS 10 0.0007
582 ENTEROCOLITIS 4 0.0007
583 MONOPLEGIA 3 0.0007
584 CARDIAC ARREST 57 0.0007
585 RESPIRATORY DISTRESS 19 0.0007
586 SUBARACHNOID HAEMORRHAGE 7 0.0007
587 HYPERTRIGLYCERIDAEMIA 4 0.0007
588 IMMUNE SYSTEM DISORDER 9 0.0007
589 PARONYCHIA 3 0.0007
590 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
591 ODYNOPHAGIA 4 0.0007
592 HAEMORRHAGE INTRACRANIAL 10 0.0007
593 PLATELET COUNT ABNORMAL 4 0.0007
594 TROPONIN INCREASED 5 0.0007
595 CHEST X-RAY ABNORMAL 2 0.0007
596 HAEMOLYSIS 5 0.0006
597 ILEUS 8 0.0006
598 BLOOD BLISTER 2 0.0006
599 BRAIN FOG 10 0.0006
600 CHILLS 74 0.0006
601 PROTEINURIA 12 0.0006
602 PULSE ABSENT 3 0.0006
603 HEPATOTOXICITY 14 0.0006
604 METABOLIC ACIDOSIS 20 0.0006
605 GASTROINTESTINAL HAEMORRHAGE 52 0.0006
606 DECUBITUS ULCER 5 0.0006
607 HICCUPS 5 0.0006
608 WALKING AID USER 4 0.0006
609 PULMONARY OEDEMA 27 0.0006
610 ELECTROLYTE IMBALANCE 7 0.0006
611 CARDIAC FAILURE ACUTE 4 0.0006
612 FULL BLOOD COUNT DECREASED 12 0.0006
613 BRONCHIECTASIS 4 0.0006
614 PNEUMONIA 192 0.0006
615 SPEECH DISORDER 31 0.0006
616 BODY TEMPERATURE INCREASED 12 0.0006
617 HYPOPHAGIA 15 0.0006
618 CEREBRAL HAEMORRHAGE 21 0.0006
619 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
620 INFARCTION 4 0.0006
621 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
622 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
623 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
624 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
625 HYPERREFLEXIA 2 0.0006
626 MUCOSAL INFLAMMATION 15 0.0006
627 OXYGEN SATURATION DECREASED 32 0.0006
628 URINARY RETENTION 19 0.0006
629 DEEP VEIN THROMBOSIS 37 0.0006
630 DEPRESSIVE SYMPTOM 2 0.0006
631 DUODENAL ULCER 4 0.0006
632 CHEST DISCOMFORT 58 0.0006
633 FACIAL PARESIS 2 0.0006
634 ISCHAEMIC STROKE 10 0.0006
635 SUBDURAL HAEMATOMA 8 0.0006
636 CARDIOGENIC SHOCK 8 0.0006
637 ANAL ABSCESS 3 0.0006
638 ANAL INCONTINENCE 5 0.0006
639 HEART RATE ABNORMAL 3 0.0005
640 HYDRONEPHROSIS 4 0.0005
641 PERONEAL NERVE PALSY 3 0.0005
642 DISTURBANCE IN ATTENTION 28 0.0005
643 HYPOVOLAEMIA 3 0.0005
644 HAEMORRHAGIC STROKE 4 0.0005
645 VIRAL INFECTION 17 0.0005
646 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
647 URINARY INCONTINENCE 15 0.0005
648 DECREASED APPETITE 117 0.0005
649 RESPIRATORY TRACT INFECTION 13 0.0005
650 CELLULITIS 25 0.0005
651 ENURESIS 2 0.0005
652 DYSPHAGIA 47 0.0005
653 NEOPLASM MALIGNANT 33 0.0005
654 LACTIC ACIDOSIS 16 0.0005
655 MUSCLE DISORDER 4 0.0005
656 UNEVALUABLE EVENT 37 0.0005
657 DEMYELINATION 2 0.0005
658 LARYNGEAL OEDEMA 3 0.0005
659 LETHARGY 28 0.0005
660 HYPERURICAEMIA 2 0.0005
661 ACUTE CORONARY SYNDROME 4 0.0005
662 GAIT INABILITY 16 0.0005
663 FACE OEDEMA 8 0.0005
664 PULMONARY MASS 7 0.0005
665 HYPERGLYCAEMIA 17 0.0005
666 LIVER FUNCTION TEST INCREASED 10 0.0005
667 ANURIA 4 0.0005
668 MYOPATHY 4 0.0005
669 LUNG NEOPLASM MALIGNANT 19 0.0005
670 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
671 URINE OUTPUT DECREASED 4 0.0005
672 HYPERKALAEMIA 16 0.0005
673 ASTHENIA 171 0.0005
674 MENTAL IMPAIRMENT 11 0.0005
675 RESPIRATORY RATE INCREASED 4 0.0005
676 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
677 MYOSITIS 4 0.0004
678 NEPHROPATHY TOXIC 5 0.0004
679 PNEUMOTHORAX 7 0.0004
680 PRODUCTIVE COUGH 21 0.0004
681 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
682 DISEASE COMPLICATION 2 0.0004
683 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
684 BRAIN NEOPLASM 4 0.0004
685 BRADYCARDIA 23 0.0004
686 LARGE INTESTINE PERFORATION 3 0.0004
687 COLITIS 16 0.0004
688 METASTASIS 3 0.0004
689 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
690 RED BLOOD CELL COUNT DECREASED 12 0.0004
691 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
692 AUTOIMMUNE DISORDER 4 0.0004
693 CEREBRAL INFARCTION 10 0.0004
694 TREATMENT FAILURE 33 0.0004
695 DYSPHORIA 2 0.0004
696 HYPOTHERMIA 4 0.0004
697 TOOTH ABSCESS 4 0.0004
698 CEREBRAL ISCHAEMIA 2 0.0004
699 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
700 VENTRICULAR EXTRASYSTOLES 4 0.0004
701 LIVER DISORDER 17 0.0004
702 FOLLICULITIS 4 0.0004
703 MOUTH ULCERATION 8 0.0004
704 SUDDEN DEATH 4 0.0004
705 TRANSPLANT REJECTION 3 0.0004
706 BEHAVIOUR DISORDER 2 0.0004
707 MUSCULAR WEAKNESS 42 0.0004
708 ABNORMAL FAECES 3 0.0004
709 HERPES ZOSTER 21 0.0004
710 ARRHYTHMIA 17 0.0004
711 ORAL HERPES 7 0.0004
712 HAEMODIALYSIS 3 0.0004
713 PERICARDITIS 6 0.0004
714 BLOOD TEST ABNORMAL 5 0.0004
715 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
716 HAEMATOCRIT DECREASED 7 0.0004
717 HEPATOCELLULAR INJURY 5 0.0004
718 IMPAIRED DRIVING ABILITY 4 0.0004
719 MICTURITION URGENCY 4 0.0003
720 SPINAL FRACTURE 7 0.0003
721 GASTRIC HAEMORRHAGE 4 0.0003
722 PULMONARY EMBOLISM 33 0.0003
723 DIPLOPIA 9 0.0003
724 PYELONEPHRITIS 3 0.0003
725 BLINDNESS 14 0.0003
726 FATIGUE 263 0.0003
727 RENAL IMPAIRMENT 28 0.0003
728 THYROID CANCER 4 0.0003
729 OROPHARYNGEAL DISCOMFORT 3 0.0003
730 BLOOD PRESSURE DECREASED 22 0.0003
731 BLOOD COUNT ABNORMAL 5 0.0003
732 MYALGIA 55 0.0003
733 CHOLANGITIS 2 0.0003
734 HEPATIC FUNCTION ABNORMAL 12 0.0003
735 CEREBROVASCULAR ACCIDENT 54 0.0003
736 THERAPEUTIC RESPONSE DECREASED 19 0.0003
737 ENTERITIS 2 0.0003
738 CARDIAC FAILURE 25 0.0003
739 HAEMOGLOBIN ABNORMAL 2 0.0003
740 AMNESIA 20 0.0003
741 HEADACHE 192 0.0003
742 HOSPICE CARE 3 0.0003
743 BLADDER DISORDER 3 0.0003
744 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
745 BLOOD PRESSURE ABNORMAL 6 0.0003
746 RESPIRATORY DISORDER 9 0.0003
747 TOXIC SKIN ERUPTION 3 0.0003
748 COLITIS ISCHAEMIC 2 0.0003
749 FEEDING DISORDER 6 0.0003
750 PERIPHERAL COLDNESS 4 0.0003
751 INTERSTITIAL LUNG DISEASE 14 0.0003
752 DIVERTICULITIS 8 0.0003
753 PRESYNCOPE 7 0.0003
754 EXTRASYSTOLES 2 0.0003
755 RENAL FAILURE 38 0.0003
756 METASTASES TO LIVER 5 0.0003
757 NEUROPATHY PERIPHERAL 27 0.0003
758 FULL BLOOD COUNT ABNORMAL 3 0.0003
759 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
760 MALAISE 121 0.0003
761 BLOOD CREATININE INCREASED 18 0.0003
762 PELVIC PAIN 5 0.0003
763 FAECES SOFT 2 0.0003
764 WOUND INFECTION 3 0.0003
765 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
766 SINUSITIS 28 0.0003
767 DUODENAL ULCER PERFORATION 2 0.0003
768 SKIN INFECTION 3 0.0003
769 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
770 LUNG DISORDER 13 0.0003
771 MYOCARDITIS 3 0.0003
772 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
773 VASCULITIS 3 0.0003
774 PNEUMONITIS 7 0.0003
775 AFFECTIVE DISORDER 2 0.0003
776 HALLUCINATION, AUDITORY 4 0.0003
777 OEDEMA PERIPHERAL 30 0.0002
778 RESTLESSNESS 9 0.0002
779 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
780 HYPERAESTHESIA 2 0.0002
781 PHARYNGITIS 3 0.0002
782 ABDOMINAL PAIN 56 0.0002
783 HEMIPLEGIA 2 0.0002
784 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
785 LABORATORY TEST ABNORMAL 7 0.0002
786 EATING DISORDER 5 0.0002
787 HEPATIC ENZYME INCREASED 16 0.0002
788 HAEMATURIA 8 0.0002
789 PARANOIA 4 0.0002
790 MENTAL DISORDER 10 0.0002
791 DRUG-INDUCED LIVER INJURY 7 0.0002
792 OFF LABEL USE 191 0.0002
793 MOVEMENT DISORDER 7 0.0002
794 COUGH 61 0.0002
795 MUSCLE TWITCHING 5 0.0002
796 DRUG INEFFECTIVE 285 0.0002
797 FEELING COLD 6 0.0002
798 INFLUENZA 24 0.0002
799 MASS 3 0.0002
800 LOSS OF CONSCIOUSNESS 27 0.0002
801 EXPIRED PRODUCT ADMINISTERED 7 0.0002
802 CHOLESTASIS 4 0.0002
803 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
804 DIZZINESS POSTURAL 2 0.0002
805 NEURALGIA 5 0.0002
806 BONE PAIN 12 0.0002
807 ACUTE MYOCARDIAL INFARCTION 6 0.0002
808 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
809 EMPHYSEMA 2 0.0002
810 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
811 ANAPHYLACTIC SHOCK 5 0.0002
812 GAIT DISTURBANCE 37 0.0002
813 PERITONITIS 4 0.0002
814 DIARRHOEA 124 0.0002
815 DEAFNESS 5 0.0002
816 DYSURIA 7 0.0002
817 ULCER 3 0.0002
818 VOMITING 86 0.0002
819 GASTROINTESTINAL PAIN 2 0.0002
820 RESPIRATORY ARREST 5 0.0002
821 ANGIOEDEMA 8 0.0002
822 HYPERTENSION 38 0.0002
823 HAEMOPTYSIS 5 0.0002
824 GASTROINTESTINAL DISORDER 16 0.0002
825 CIRCULATORY COLLAPSE 3 0.0002
826 URINARY TRACT INFECTION 30 0.0002
827 HAEMOGLOBIN DECREASED 18 0.0002
828 PARAESTHESIA 27 0.0002
829 EOSINOPHILIA 3 0.0002
830 HEAD DISCOMFORT 3 0.0002
831 SWELLING FACE 11 0.0002
832 LIVER INJURY 4 0.0002
833 HEPATIC STEATOSIS 3 0.0002
834 THINKING ABNORMAL 3 0.0002
835 TOXICITY TO VARIOUS AGENTS 27 0.0002
836 HEAD INJURY 5 0.0002
837 GASTRIC ULCER 3 0.0002
838 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
839 HAEMATOMA 4 0.0002
840 BALANCE DISORDER 13 0.0002
841 SYNCOPE 15 0.0001
842 NAUSEA 118 0.0001
843 PAIN OF SKIN 4 0.0001
844 TASTE DISORDER 3 0.0001
845 DYSKINESIA 6 0.0001
846 AKATHISIA 2 0.0001
847 ACUTE HEPATIC FAILURE 2 0.0001
848 RIB FRACTURE 3 0.0001
849 ILLNESS 15 0.0001
850 POLLAKIURIA 6 0.0001
851 HUNGER 2 0.0001
852 COORDINATION ABNORMAL 2 0.0001
853 BLINDNESS UNILATERAL 2 0.0001
854 CONDITION AGGRAVATED 43 0.0001
855 AGGRESSION 7 0.0001
856 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
857 ACCIDENTAL UNDERDOSE 2 0.0001
858 VISION BLURRED 19 0.0001
859 BACK PAIN 32 0.0001
860 PRODUCT PRESCRIBING ISSUE 3 0.0001
861 MELAENA 3 0.0001
862 FALL 45 0.0001
863 DYSPNOEA 76 0.0001
864 COLON CANCER 2 0.0001
865 ABDOMINAL DISTENSION 14 0.0001
866 HALLUCINATION 10 0.0001
867 HEART RATE INCREASED 13 0.0001
868 DEVICE RELATED INFECTION 2 0.0001
869 ANKLE FRACTURE 2 0.0001
870 DELUSION 2 0.0001
871 PLASMA CELL MYELOMA 5 0.0001
872 HYPOAESTHESIA 19 0.0001
873 ANAPHYLACTIC REACTION 7 0.0001
874 RASH ERYTHEMATOUS 6 0.0001
875 THROMBOSIS 10 0.0001
876 NIGHT SWEATS 4 0.0001
877 SKIN DISORDER 4 0.0001
878 DYSPHONIA 7 0.0001
879 ANGER 4 0.0001
880 FLUID RETENTION 6 0.0001
881 HEPATITIS 3 0.0001
882 DRUG RESISTANCE 3 0.0001
883 HYPERHIDROSIS 15 0.0001
884 HYPOACUSIS 5 0.0001
885 VERTIGO 7 0.0001
886 PANCREATITIS 6 0.0001
887 GALLBLADDER DISORDER 2 0.0001
888 JAUNDICE 3 0.0001
889 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
890 CONJUNCTIVITIS 2 0.0001
891 WEIGHT DECREASED 30 0.0001
892 BLOOD SODIUM DECREASED 2 0.0001
893 INSOMNIA 28 0.0001
894 FEELING JITTERY 2 0.0001
895 LIVER FUNCTION TEST ABNORMAL 3 0.0001
896 EAR PAIN 2 0.0001
897 DYSSTASIA 3 0.0001
898 PSYCHOTIC DISORDER 3 0.0001
899 ABNORMAL BEHAVIOUR 4 0.0001
900 PAIN 62 0.0001
901 BLOOD POTASSIUM DECREASED 3 0.0001
902 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
903 PERIPHERAL SWELLING 15 0.0001
904 HAEMORRHAGE 10 0.0001
905 DERMATITIS 2 0.0001
906 BRONCHITIS 7 0.0001
907 DYSGEUSIA 7 0.0001
908 OEDEMA 5 0.0001
909 VISUAL ACUITY REDUCED 3 0.0001
910 RASH 39 0.0001
911 BLISTER 5 0.0001
912 PAIN IN EXTREMITY 26 0.0001
913 PROSTATE CANCER 7 0.0001
914 CHEST PAIN 16 0.0001
915 DIZZINESS 43 0.0001
916 MYOCARDIAL INFARCTION 15 0.0001
917 RENAL DISORDER 4 0.0001
918 CARDIAC DISORDER 8 0.0001
919 SWELLING 8 0.0001
920 SURGERY 5 0.0001
921 MOBILITY DECREASED 6 0.0001
922 BLOOD PRESSURE FLUCTUATION 2 0.0001
923 CONSTIPATION 18 0.0001
924 DYSPNOEA EXERTIONAL 3 0.0001
925 FEELING ABNORMAL 19 0.0001
926 HAEMATEMESIS 2 0.0001
927 CARDIOVASCULAR DISORDER 2 0.0001
928 ABORTION SPONTANEOUS 3 0.0001
929 VISUAL IMPAIRMENT 9 0.0001
930 HAEMATOCHEZIA 4 0.0001
931 RHABDOMYOLYSIS 3 0.0001
932 NECK PAIN 4 0.0001
933 DEMENTIA 2 0.0001
934 DYSPEPSIA 7 0.0001
935 HYPERSOMNIA 2 0.0001
936 DEHYDRATION 9 0.0001
937 ARTHRALGIA 28 0.0001
938 EPISTAXIS 5 0.0001
939 STOMATITIS 4 0.0001
940 NEPHROLITHIASIS 3 0.0001
941 EMOTIONAL DISORDER 2 0.0001
942 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
943 BREAST CANCER 6 0.0001
944 PRODUCT USE ISSUE 12 0.0001
945 ANXIETY 18 0.0001
946 ERYTHEMA 13 0.0001
947 MIGRAINE 6 0.0001
948 MULTIPLE SCLEROSIS 3 0.0001
949 HIP FRACTURE 2 0.0001
950 RHINORRHOEA 4 0.0001
951 HYPOGLYCAEMIA 3 0.0001
952 CHOLELITHIASIS 2 0.0001
953 PALPITATIONS 7 0.0001
954 INFLAMMATION 3 0.0001
955 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
956 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
957 CRYING 2 0.0001
958 TREATMENT NONCOMPLIANCE 3 0.0001
959 ARTHROPATHY 3 0.0001
960 EYE SWELLING 2 0.0001
961 HOT FLUSH 4 0.0001
962 DEPRESSION 12 0.0001
963 INFLUENZA LIKE ILLNESS 4 0.0000
964 DEVICE LEAKAGE 2 0.0000
965 ABDOMINAL PAIN UPPER 9 0.0000
966 ADVERSE EVENT 4 0.0000
967 URTICARIA 7 0.0000
968 ABDOMINAL DISCOMFORT 7 0.0000
969 ALOPECIA 8 0.0000
970 DRY EYE 2 0.0000
971 CHRONIC KIDNEY DISEASE 3 0.0000
972 FLUSHING 4 0.0000
973 PRURITUS 15 0.0000
974 NO ADVERSE EVENT 7 0.0000
975 ECZEMA 2 0.0000
976 DEPRESSED MOOD 2 0.0000
977 CARDIAC FAILURE CONGESTIVE 3 0.0000
978 COMPLETED SUICIDE 3 0.0000
979 EYE PAIN 2 0.0000
980 DISCOMFORT 2 0.0000
981 NASOPHARYNGITIS 6 0.0000
982 OROPHARYNGEAL PAIN 3 0.0000
983 DRUG INTERACTION 5 0.0000
984 WEIGHT INCREASED 7 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
986 DIABETES MELLITUS 2 0.0000
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
988 ADVERSE DRUG REACTION 2 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
990 HYPERSENSITIVITY 4 0.0000
991 CONTUSION 2 0.0000
992 BLOOD PRESSURE INCREASED 2 0.0000